SuperworthHarmony Biosciences shares outstanding HRMY
Diluted shares outstanding, averaged over each quarter, from 2019.
- Latest quarter, to Jun 30, 2026
- 58.8M
- On a year earlier
- +0.6%
- more shares
Harmony Biosciences had 58.8M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 0.6% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 58M | −0% |
| FY2024 | 58.2M | −1% |
| FY2023 | 58.8M | −5% |
| FY2022 | 61.6M | +2% |
| FY2021 | 60.5M | +6% |
| FY2020 | 56.9M | +631% |
| FY2019 | 7.8M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 58.8M | +1% | |
| Q1 FY26 | 58.8M | +0% | |
| Q4 FY25 | 58M | −0% | |
| Q3 FY25 | 58.7M | +1% | |
| Q2 FY25 | 58.4M | +2% | |
| Q1 FY25 | 58.5M | +2% | |
| Q4 FY24 | 58.2M | −1% | |
| Q3 FY24 | 58.1M | −4% | |
| Q2 FY24 | 57.5M | −5% | |
| Q1 FY24 | 57.6M | −6% | |
| Q4 FY23 | 58.8M | −5% | |
| Q3 FY23 | 60.7M | −1% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Harmony Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.